Logo image of LIPO

LIPELLA PHARMACEUTICALS INC (LIPO) Stock Analyst Ratings

USA - Nasdaq - NASDAQ:LIPO - US53630L2097 - Common Stock

2.36 USD
-0.35 (-12.75%)
Last: 6/18/2025, 8:03:30 PM
1.8001 USD
-0.56 (-23.72%)
After Hours: 6/18/2025, 8:03:30 PM
Buy % Consensus

83

ChartMill assigns a Buy % Consensus number of 83% to LIPO. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 10.2. This target is 332.2% above the current price.
LIPO was analyzed by 7 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about LIPO.
In the previous month the buy percentage consensus was at a similar level.
LIPO was analyzed by 7 analysts. More opinions would make the average more meaningful.
LIPO Historical Analyst RatingsLIPO Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -13 -12 -11 -10 -9 -8 -7 -6 -5 -4 -3 -2 -1 0 2 4 6

Price Target & Forecast

Price Low Median Mean High 2.3610.1010.2010.2010.50 - 327.97% 332.20% 332.20% 344.92%
LIPO Current Analyst RatingLIPO Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0 0 0 0 0
Up and Down Grades
Date Firm Action Rating
2024-04-09 Maxim Group Initiate Buy

LIPELLA PHARMACEUTICALS INC / LIPO FAQ

Can you provide the average price target for LIPELLA PHARMACEUTICALS INC stock?

7 analysts have analysed LIPO and the average price target is 10.2 USD. This implies a price increase of 332.2% is expected in the next year compared to the current price of 2.36.


What is the consensus rating for LIPO stock?

The consensus rating for LIPELLA PHARMACEUTICALS INC (LIPO) is 82.8571 / 100 . This indicates that analysts generally have a positive outlook on the stock.


Can you provide the analyst count for LIPELLA PHARMACEUTICALS INC stock?

The number of analysts covering LIPELLA PHARMACEUTICALS INC (LIPO) is 7.